Medline to buy Teleflex's respiratory business for $286M

Medical technology company Teleflex signed a definitive agreement to sell part of its respiratory business to medical supplier Medline Industries, according to a May 18 press release.

The transaction is expected to close in the third quarter of this year and generate $286 million. Some of the product lines that Teleflex will divest include oxygen and aerosol therapy, active humidification, noninvasive ventilation, and incentive spirometers. These products generated $139 million in revenue in 2020. Teleflex entered the agreement with Medline to pay down debt and drive focus toward achieving long-term goals for the company.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like